{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:33:50Z","timestamp":1788150830738,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00266-024-04539-4","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:37:55Z","timestamp":1733161075000},"page":"2305-2314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Meta-Analysis of Adverse Reactions of Botulinum Toxin A in Facial Rejuvenation Treatment"],"prefix":"10.1007","volume":"49","author":[{"given":"Weiqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"4539_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1124\/pr.116.012658","volume":"69","author":"M Pirazzini","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R, Montecucco C (2017) Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev 69:200\u2013235","journal-title":"Pharmacol Rev"},{"issue":"5","key":"4539_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/toxins8050154","volume":"8","author":"J Weisemann","year":"2016","unstructured":"Weisemann J, Stern D, Mahrhold S, Dorner BG, Rummel A (2016) Botulinum neurotoxin serotype a recognizes its protein receptor SV2 by a different mechanism than botulinum neurotoxin B synaptotagmin. Toxins 8(5):154","journal-title":"Toxins"},{"issue":"2","key":"4539_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/toxins14020120","volume":"14","author":"B Wabbels","year":"2022","unstructured":"Wabbels B, Fimmers R, Roggenk\u00e4mper P (2022) Ultra-long-term therapy of benign essential blepharospasm with botulinumtoxin a-30 years of experience in a tertiary care center. Toxins 14(2):120","journal-title":"Toxins"},{"key":"4539_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/bph.14846","volume":"177","author":"I Matak","year":"2019","unstructured":"Matak I (2019) Evidence for central antispastic effect of botulinum toxin type A. Br J Pharmacol 177:65\u201376","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4539_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/JCAS.JCAS_162_21","volume":"15","author":"R Kandhari","year":"2022","unstructured":"Kandhari R, Kaur I, Gupta J, Al-Niaimi F (2022) Microdroplet botulinum toxin: a review. J Cutan Aesthet Surg 15(2):101\u2013107","journal-title":"J Cutan Aesthet Surg"},{"issue":"8","key":"4539_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00403-021-02277-0","volume":"314","author":"E Hanna","year":"2022","unstructured":"Hanna E, Xing L, Taylor JH, Bertucci V (2022) Role of botulinum toxin A in improving facial erythema and skin quality. Arch Dermatol Res 314(8):729\u2013738","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"4539_CR7","first-page":"22","volume":"13","author":"EM Atwa","year":"2020","unstructured":"Atwa EM, Nasr MM, Ebrahim HM (2020) Evaluation of intradermal injection of botulinum toxin a for facial lifting. J Clin Aesthet Dermatol 13(12):22\u201326","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"4539_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00266-016-0682-1","volume":"40","author":"Z Jia","year":"2016","unstructured":"Jia Z, Lu H, Yang X, Jin X, Wu R, Zhao J, Chen L, Qi Z (2016) Adverse events of botulinum toxin type a in facial rejuvenation: a systematic review and meta-analysis. Aesth Plast Surg 40(5):769\u2013777. https:\/\/doi.org\/10.1007\/s00266-016-0682-1","journal-title":"Aesthetic Plast Surg"},{"issue":"5","key":"4539_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/asj\/sjac036","volume":"42","author":"D Zargaran","year":"2022","unstructured":"Zargaran D, Zoller F, Zargaran A, Rahman E, Woollard A, Weyrich T, Mosahebi A (2022) Complications of cosmetic botulinum Toxin A injections to the upper face: a systematic review and meta-analysis. Aesthet Surg J 42(5):327\u2013336. https:\/\/doi.org\/10.1093\/asj\/sjac036","journal-title":"Aesthet Surg J"},{"issue":"1","key":"4539_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/IOP.0000000000002169","volume":"39","author":"M Gostimir","year":"2023","unstructured":"Gostimir M, Liou V, Yoon MK (2023) Safety of botulinum toxin A injections for facial rejuvenation: a meta-analysis of 9,669 patients. Ophthalmic Plast Reconstr Surg 39(1):13\u201325. https:\/\/doi.org\/10.1097\/IOP.0000000000002169","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"4539_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/asj\/sjw272","volume":"38","author":"B Ascher","year":"2018","unstructured":"Ascher B, Kestemont P, Boineau D, Bodokh I, Stein A, Heckmann M, Dendorfer M, Pavicic T, Volteau M, Tse A, Picaut P, Rzany B (2018) Liquid formulation of abobotulinumtoxin A exhibits a favorable efficacy and safety profile in moderate to severe glabellar lines: a randomized, double-blind, placebo- and active comparator-controlled trial. Aesthet Surg J 38(2):183\u2013191. https:\/\/doi.org\/10.1093\/asj\/sjw272","journal-title":"Aesthet Surg J"},{"issue":"1","key":"4539_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/asj\/sjz003","volume":"40","author":"B Ascher","year":"2020","unstructured":"Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P (2020) Liquid formulation of AbobotulinumtoxinA: a 6-month, phase 3, double-blind, randomized, placebo-controlled study of a single treatment, ready-to-use toxin for moderate-to-severe glabellar lines. Aesthet Surg J 40(1):93\u2013104","journal-title":"Aesthet Surg J"},{"issue":"10","key":"4539_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1524-4725.2009.01261.x","volume":"35","author":"B Ascher","year":"2009","unstructured":"Ascher B, Rzany BJ, Grover R (2009) Efficacy and safety of botulinum toxin type A in the treatment of lateral crow\u2019s feet: double-blind, placebo-controlled, dose-ranging study. Dermatol Surg 35(10):1478\u20131486. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01261.x","journal-title":"Dermatol Surg"},{"issue":"11","key":"4539_CR14","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1097\/DSS.0000000000001903","volume":"45","author":"KR Beer","year":"2019","unstructured":"Beer KR, Shamban AT, Avelar RL, Gross JE, Jonker A (2019) Efficacy and safety of PrabotulinumtoxinA for the treatment of glabellar lines in adult subjects: results from 2 identical phase III studies. Dermatol Surg 45(11):1381\u20131393","journal-title":"Dermatol Surg"},{"issue":"4","key":"4539_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jaad.2019.06.1313","volume":"82","author":"V Bertucci","year":"2020","unstructured":"Bertucci V, Solish N, Kaufman-Janette J, Yoelin S, Shamban A, Schlessinger J, Snyder D, Gallagher C, Liu Y, Shears G, Rubio RG (2020) DaxibotulinumtoxinA for injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). J Am Acad Dermatol 82(4):838\u2013845. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1313","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"4539_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/DSS.0000000000000128","volume":"40","author":"A Carruthers","year":"2014","unstructured":"Carruthers A, Bruce S, de Coninck A, Connolly S, Cox SE, Davis PG, Campo A, Lei X, Somogyi C, Lee E, McLean H, Beddingfield F (2014) Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial. Dermatol Surg 40(11):1181\u20131190. https:\/\/doi.org\/10.1097\/DSS.0000000000000128","journal-title":"Dermatol Surg"},{"issue":"6","key":"4539_CR17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/DSS.0000000000000357","volume":"41","author":"J Carruthers","year":"2015","unstructured":"Carruthers J, Rivkin A, Donofrio L, Bertucci V, Somogyi C, Lei X, Davis PG, Campo A, Beddingfield FC (2015) A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of repeated onabotulinumtoxina treatments in subjects with crow\u2019s feet lines and glabellar lines. Dermatol Surg 41(6):702\u2013711. https:\/\/doi.org\/10.1097\/DSS.0000000000000357","journal-title":"Dermatol Surg"},{"issue":"11","key":"4539_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1097\/DSS.0000000000001206","volume":"43","author":"J Carruthers","year":"2017","unstructured":"Carruthers J, Solish N, Humphrey S, Rosen N, Muhn C, Bertucci V, Swift A, Metelitsa A, Rubio RG, Waugh J, Quiring J, Shears G, Carruthers A (2017) Injectable DaxibotulinumtoxinA for the treatment of glabellar lines: a phase 2, randomized, dose-ranging, double-blind, Multicenter comparison With OnabotulinumtoxinA and Placebo. Dermatol Surg 43(11):1321\u20131331. https:\/\/doi.org\/10.1097\/DSS.0000000000001206","journal-title":"Dermatol Surg"},{"issue":"11","key":"4539_CR19","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1097\/DSS.0000000000001612","volume":"44","author":"K De Boulle","year":"2018","unstructured":"De Boulle K, Werschler WP, Gold MH, Bruce S, Sattler G, Ogilvie P, Street J, Larsen KE, Yushmanova I, Lei X, Lee E, Vitarella D, Mao C (2018) Phase 3 study of OnabotulinumtoxinA distributed between frontalis, glabellar complex, and lateral Canthal areas for treatment of upper facial lines. Dermatol Surg 44(11):1437\u20131448. https:\/\/doi.org\/10.1097\/DSS.0000000000001612","journal-title":"Dermatol Surg"},{"issue":"Suppl 3","key":"4539_CR20","doi-asserted-by":"publisher","first-page":"S274","DOI":"10.1097\/DSS.0000000000001414","volume":"43","author":"S Fagien","year":"2017","unstructured":"Fagien S, Cohen JL, Coleman W, Monheit G, Carruthers J, Street J, Larsen KE, Yushmanova I, Lei X, Lee E, Vitarella D, Mao C (2017) Forehead line treatment with OnabotulinumtoxinA in subjects with forehead and glabellar facial Rhytids: a phase 3 study. Dermatol Surg 43(Suppl 3):S274\u2013S284. https:\/\/doi.org\/10.1097\/DSS.0000000000001414","journal-title":"Dermatol Surg"},{"issue":"5","key":"4539_CR21","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s00266-017-0844-9","volume":"41","author":"K Harii","year":"2017","unstructured":"Harii K, Kawashima M, Furuyama N, Lei X, Hopfinger R, Lee E (2017) OnabotulinumtoxinA (Botox) in the Treatment of crow\u2019s feet lines in Japanese subjects. Aesth Plast Surg 41(5):1186\u20131197. https:\/\/doi.org\/10.1007\/s00266-017-0844-9","journal-title":"Aesthetic Plast Surg"},{"issue":"2","key":"4539_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/DSS.0000000000002047","volume":"46","author":"TC Keaney","year":"2020","unstructured":"Keaney TC, Cavallini M, Leys C, Rossi A, Drinkwater A, Manson Brown S, Garcia JK, Mao C (2020) Efficacy, patient-reported outcomes, and safety in male subjects treated With OnabotulinumtoxinA for improvement of moderate to severe horizontal forehead lines. Dermatol Surg 46(2):229\u2013239. https:\/\/doi.org\/10.1097\/DSS.0000000000002047","journal-title":"Dermatol Surg"},{"issue":"10","key":"4539_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/DSS.0000000000000450","volume":"41","author":"M Kerscher","year":"2015","unstructured":"Kerscher M, Rzany B, Prager W, Turnbull C, Trevidic P, Inglefield C (2015) Efficacy and safety of IncobotulinumtoxinA in the treatment of upper facial lines: results from a randomized, double-blind, placebo-controlled. Phase III Study. Dermatol Surg. 41(10):1149\u20131157. https:\/\/doi.org\/10.1097\/DSS.0000000000000450","journal-title":"Phase III Study. Dermatol Surg."},{"issue":"3","key":"4539_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1524-4725.2005.31070","volume":"31","author":"NJ Lowe","year":"2005","unstructured":"Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N (2005) Botox facial aesthetics study team. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow\u2019s feet. Dermatol Surg 31(3):257\u2013262. https:\/\/doi.org\/10.1111\/j.1524-4725.2005.31070","journal-title":"Dermatol Surg"},{"issue":"1","key":"4539_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/DSS.0000000000000220","volume":"41","author":"M Moers-Carpi","year":"2015","unstructured":"Moers-Carpi M, Carruthers J, Fagien S, Lupo M, Delmar H, Jones D, Somogyi C, Lee E, Lei X, MacKinnon S, Davis PG, Yalamanchili R, Campo A, Beddingfield FC 3rd (2015) Efficacy and safety of onabotulinumtoxinA for treating crow\u2019s feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial. Dermatol Surg 41(1):102\u2013112. https:\/\/doi.org\/10.1097\/DSS.0000000000000220","journal-title":"Dermatol Surg"},{"issue":"1","key":"4539_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/DSS.0000000000002013","volume":"46","author":"GD Monheit","year":"2020","unstructured":"Monheit GD, Baumann L, Maas C, Rand R, Down R (2020) Efficacy, safety, and subject satisfaction after AbobotulinumtoxinA treatment for moderate to severe glabellar lines. Dermatol Surg 46(1):61\u201369. https:\/\/doi.org\/10.1097\/DSS.0000000000002013","journal-title":"Dermatol Surg"},{"issue":"5","key":"4539_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/DSS.0000000000002216","volume":"46","author":"MD Palm","year":"2020","unstructured":"Palm MD, Few J, Patel T, Safa M, Drinkwater A, Mao C, Garcia JK (2020) Efficacy, patient-reported outcomes, and safety for millennial subjects treated with OnabotulinumtoxinA for moderate to severe horizontal forehead lines. Dermatol Surg 46(5):653\u2013661. https:\/\/doi.org\/10.1097\/DSS.0000000000002216","journal-title":"Dermatol Surg"},{"issue":"4","key":"4539_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/asj\/sjz110","volume":"40","author":"BJ Rzany","year":"2020","unstructured":"Rzany BJ, Ascher B, Avelar RL, Bergdahl J, Bertucci V, Bodokh I, Carruthers JA, Cartier H, Delmar H, Denfeld R, Gross JE, Heckmann M, Hed\u00e9n P, Hilton S, Inglefield C, Ogilvie P, Sattler G, Sebastian M, Solish N, Swift A, Tr\u00e9vidic P (2020) A Multicenter, randomized, double-blind, placebo-controlled, single-dose, phase III, non-inferiority study comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the treatment of moderate to severe glabellar lines in adult patients. Aesthet Surg J 40(4):413\u2013429. https:\/\/doi.org\/10.1093\/asj\/sjz110","journal-title":"Aesthet Surg J"},{"issue":"3","key":"4539_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/DSS.0000000000000626","volume":"42","author":"N Solish","year":"2016","unstructured":"Solish N, Rivers JK, Humphrey S, Muhn C, Somogyi C, Lei X, Bhogal M, Caulkins C (2016) Efficacy and safety of OnabotulinumtoxinA treatment of forehead lines: a Multicenter, randomized. Dose-Ranging Controll Trial. Dermatol Surg 42(3):410\u2013419. https:\/\/doi.org\/10.1097\/DSS.0000000000000626","journal-title":"Dose-Ranging Controll Trial. Dermatol Surg"},{"issue":"1","key":"4539_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000002079","volume":"7","author":"Y Wu","year":"2019","unstructured":"Wu Y, Wang G, Li C, Mao C, Lei X, Lee E (2019) Safety and efficacy of OnabotulinumtoxinA for treatment of crow\u2019s feet lines in chinese subjects. Plast Reconstr Surg Glob Open 7(1):e2079. https:\/\/doi.org\/10.1097\/GOX.0000000000002079","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"4539_CR31","doi-asserted-by":"publisher","first-page":"265e","DOI":"10.1097\/PRS.0000000000003544","volume":"140","author":"M De Maio","year":"2017","unstructured":"De Maio M, Swift A, Signorini M, Fagien S (2017) Facial assessment and injection guide for Botulinum Toxin and injectable hyaluronic acid fillers. Plast Reconstr Surg 140:265e\u2013276e","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"4539_CR32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/asj\/sjw025","volume":"36","author":"A Carruthers","year":"2016","unstructured":"Carruthers A, Bruce S, Cox SE, Kane MA, Lee E, Gallagher CJ (2016) OnabotulinumtoxinA for treatment of moderate to severe crow\u2019s feet lines: a review. Aesthet Surg J 36(5):591\u2013597. https:\/\/doi.org\/10.1093\/asj\/sjw025","journal-title":"Aesthet Surg J"},{"issue":"1","key":"4539_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/SCS.0000000000004073IF:0.9Q4","volume":"29","author":"K Hwang","year":"2018","unstructured":"Hwang K (2018) Revisiting the skin lines on the forehead and glabellar area. J Craniofac Surg 29(1):209\u2013211. https:\/\/doi.org\/10.1097\/SCS.0000000000004073IF:0.9Q4","journal-title":"J Craniofac Surg"},{"issue":"4","key":"4539_CR34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/toxins14040268","volume":"14","author":"KH Yi","year":"2022","unstructured":"Yi KH, Lee JH, Hu HW, Kim HJ (2022) Anatomical proposal for botulinum neurotoxin injection for glabellar frown lines. Toxins 14(4):268. https:\/\/doi.org\/10.3390\/toxins14040268","journal-title":"Toxins"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-024-04539-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-024-04539-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-024-04539-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:19:59Z","timestamp":1748963999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-024-04539-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4539"],"URL":"https:\/\/doi.org\/10.1007\/s00266-024-04539-4","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}